Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

89.59 -0.00 (-0.01%)

Streaming Delayed Price Updated: 1:06 PM EDT, Aug 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

50 51 Next >

Dexcom Stock Collapses 33% After Sales Miss Leads To $25 Million Guidance Cut ↗

July 25, 2024

Shares are poised to open Friday at their lowest point since April 2022.

Via Investor's Business Daily

Topics Earnings

Nasdaq 100 Falls To 7-Week Lows, Marks Worst 2-Day Drop In Nearly 2 Years As Tech Rout Rages On ↗

July 25, 2024

Nasdaq 100 index falls to its lowest level since June amid volatility. Despite a brief boost from Q2 GDP growth and decreasing prices, it dropped 4.7% in 2 sessions.

Via Benzinga

DexCom Stock Drops After Mixed Q2 Results, Weak Forward Guidance ↗

July 25, 2024

DexCom shares are dropping after the company reported its second-quarter financial results Thursday. Here's a look at the key figures from the report.

Via Benzinga

$100 Invested In DexCom 10 Years Ago Would Be Worth This Much Today ↗

July 25, 2024

Via Benzinga

Dexcom Reports Second Quarter 2024 Financial Results, Updates Guidance, and Announces $750 Million Share Repurchase Program

July 25, 2024

From DexCom, Inc.

Via Business Wire

NASDAQ:DXCM: a strong growth stock preparing for the next leg up?. ↗

July 15, 2024

DEXCOM INC (NASDAQ:DXCM): a strong growth stock preparing for the next leg up?.

Via Chartmill

What Analysts Are Saying About DexCom Stock ↗

July 12, 2024

Via Benzinga

Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers ↗

July 19, 2024

Abbott Laboratories is launching Lingo, an over-the-counter glucose monitoring device aimed at non-diabetic consumers, utilizing TV and guerilla marketing. CEO Robert Ford expects Lingo to become a...

Via Benzinga

2 Healthcare Stocks to Buy at a Discount ↗

July 14, 2024

Beaten-down stocks can sometimes present an opportunity.

Via The Motley Fool

Top 4 Must-Have Healthcare Stocks for Long-Term Growth

July 11, 2024

Investing in healthcare offers long-term growth and stability fueled by demographic trends, technological advancements, and rising demand.

Via MarketBeat

3 Breakthrough Medical Device Stocks to Invest In Now ↗

July 08, 2024

Uncover the potential of leading medical device stocks boasting solid fundamentals and a promising future ahead.

Via InvestorPlace

Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years ↗

July 05, 2024

Via Benzinga

Why NASDAQ:DXCM Is a Standout High-Growth Stock in a Consolidation Phase. ↗

June 24, 2024

Why DEXCOM INC (NASDAQ:DXCM) Is a Promising High-Growth Stock in the Midst of Consolidation.

Via Chartmill

Here's How Much $1000 Invested In DexCom 5 Years Ago Would Be Worth Today ↗

June 17, 2024

Via Benzinga

Peering Into DexCom's Recent Short Interest ↗

June 11, 2024

Via Benzinga

2 Top Growth Stocks to Buy With $1,000 ↗

July 04, 2024

These stocks have excellent track records of beating the market.

Via The Motley Fool

Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.

June 27, 2024

From DexCom, Inc.

Via Business Wire

Have $50K? 7 Stocks to Buy to Retire With $1 Million by 2034 ↗

June 25, 2024

These millionaire-maker stocks could turn a $50,000 investment into $1 million by 2034 if their growth trajectories remain intact.

Via InvestorPlace

Hype Hazards: 3 Stocks to Steer Clear of on Your Wealth-Building Journey ↗

June 21, 2024

Learn why DexCom, TransDigm, and Datadog, three hyped stocks trading at rich valuations, may not be the best additions to your portfolio.

Via InvestorPlace

$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,800 Today ↗

June 03, 2024

Via Benzinga

Dexcom Showcases Extensive Clinical Data at ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People With Type 2 Diabetes

June 20, 2024

From DexCom, Inc.

Via Business Wire

The 3 Best Diabetes Stocks to Buy in June 2024 ↗

June 19, 2024

There's less fear now about weight-loss drugs reducing the need for diabetes devices. Here are three diabetes stocks to buy.

Via InvestorPlace

What's New In the Consumer Tech World Last Week? News That You Should Know (June 9-June 15, 2024) ↗

June 16, 2024

Via Benzinga

Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom ↗

June 10, 2024

The FDA clearance for two new CGMs puts Abbott on track to rival Dexcom's new Stelo device.

Via Investor's Business Daily

Apple Watch Now Directly Syncs With Dexcom's G7 Glucose Monitor ↗

June 09, 2024

Dexcom Inc. has enabled direct Apple Watch connectivity for its G7 glucose monitor, allowing users to access real-time glucose data without needing an iPhone.

Via Benzinga

Dexcom G7 Now Connects Directly to Apple Watch in the U.S.

June 05, 2024

From DexCom, Inc.

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

June 04, 2024

Via Benzinga

Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems

June 03, 2024

From Dexcom, Inc.

Via Business Wire

Bull Market Buys: 2 Growth Stocks to Own for the Long Haul ↗

June 03, 2024

Innovation is paying off for both of these medical device specialists.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

May 31, 2024

Via Benzinga

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

50 51 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.